HilaryJoyceVernonMD
Pediatrics • Baltimore, MDMedical Genetics
Associate Professor of Genetic Medicine, Johns Hopkins University School of Medicine. Associate Director, Johns Hopkins Medical School MSTP program. Director, Mitochondrial Medicine Center, Johns Hopkins University School of Medicine.
Dr. Vernon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 North Wolfe Street
Rubenstein BLDG Lower Level
Baltimore, MD 21287Phone+1 443-287-9494Fax+1 410-367-3231
Education & Training
John Hopkins UniversityResidency, Pediatrics/Medical Genetics and Genomics, 2005 - 2010- Johns Hopkins UniversityResidency, Pediatrics, 2005 - 2008
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
MD State Medical License 2009 - 2025
NC State Medical License 2020 - 2022
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Pediatrics Pediatrics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia Start of enrollment: 2021 Apr 15
Roles: Principal Investigator
Publications & Presentations
PubMed
- Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome.Olivia Sniezek Carney, Kodi W Harris, Yvonne Wohlfarter, Kyuna Lee, Grant Butschek
Human Molecular Genetics. 2025-01-23 - 2 citationsPathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.Dmitrijs Rots, Sanaa Choufani, Victor Faundes, Alexander J M Dingemans, Shelagh Joss
American Journal of Human Genetics. 2024-08-08 - 3 citationsLong-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.William R Thompson, Ryan Manuel, Anthony Abbruscato, Jim Carr, John Campbell
Genetics in Medicine. 2024-07-01
Press Mentions
Barth Syndrome: A Potential Treatment for a Rare DiseaseAugust 12th, 2024
Johns Hopkins School of Medicine, Kennedy Krieger Institute Named Certified Mitochondrial Care CenterDecember 19th, 2018
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/hilary-vernon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
